Annual EBITDA
$16.64 B
+$5.76 B+52.86%
31 December 2023
Summary:
Novo Nordisk A/S annual earnings before interest, taxes, depreciation & amortization is currently $16.64 billion, with the most recent change of +$5.76 billion (+52.86%) on 31 December 2023. During the last 3 years, it has risen by +$7.56 billion (+83.25%). NVO annual EBITDA is now at all-time high.NVO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
$5.51 B
+$346.35 M+6.71%
30 September 2024
Summary:
Novo Nordisk A/S quarterly earnings before interest, taxes, depreciation & amortization is currently $5.51 billion, with the most recent change of +$346.35 million (+6.71%) on 30 September 2024. Over the past year, it has increased by +$721.58 million (+15.08%). NVO quarterly EBITDA is now at all-time high.NVO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
$20.15 B
+$721.58 M+3.71%
30 September 2024
Summary:
Novo Nordisk A/S TTM earnings before interest, taxes, depreciation & amortization is currently $20.15 billion, with the most recent change of +$721.58 million (+3.71%) on 30 September 2024. Over the past year, it has increased by +$6.07 billion (+43.11%). NVO TTM EBITDA is now at all-time high.NVO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVO EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +52.9% | +15.1% | +43.1% |
| 3 y3 years | +83.3% | +99.7% | +98.5% |
| 5 y5 years | +103.5% | +145.9% | +139.9% |
NVO EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +83.3% | at high | +288.3% | at high | +98.5% |
| 5 y | 5 years | at high | +103.9% | at high | +290.2% | at high | +146.6% |
| alltime | all time | at high | >+9999.0% | at high | +400.1% | at high | +2809.7% |
Novo Nordisk A/S EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $5.51 B(+6.7%) | $20.15 B(+3.7%) |
| June 2024 | - | $5.16 B(-4.0%) | $19.43 B(+6.9%) |
| Mar 2024 | - | $5.38 B(+30.6%) | $18.18 B(+8.3%) |
| Dec 2023 | $16.64 B(+52.9%) | $4.11 B(-14.0%) | $16.78 B(+19.2%) |
| Sept 2023 | - | $4.78 B(+22.5%) | $14.08 B(+12.5%) |
| June 2023 | - | $3.90 B(-1.8%) | $12.52 B(+6.8%) |
| Mar 2023 | - | $3.98 B(+180.5%) | $11.72 B(+7.4%) |
| Dec 2022 | $10.89 B(+4.6%) | $1.42 B(-56.0%) | $10.91 B(-6.1%) |
| Sept 2022 | - | $3.22 B(+3.8%) | $11.62 B(+4.2%) |
| June 2022 | - | $3.10 B(-2.0%) | $11.15 B(+4.8%) |
| Mar 2022 | - | $3.17 B(+49.2%) | $10.64 B(+2.2%) |
| Dec 2021 | $10.41 B(+14.6%) | $2.12 B(-23.0%) | $10.41 B(+2.5%) |
| Sept 2021 | - | $2.76 B(+6.3%) | $10.16 B(+3.9%) |
| June 2021 | - | $2.59 B(-11.7%) | $9.77 B(+3.9%) |
| Mar 2021 | - | $2.94 B(+57.0%) | $9.41 B(+4.1%) |
| Dec 2020 | $9.08 B(+11.3%) | $1.87 B(-21.2%) | $9.04 B(+5.4%) |
| Sept 2020 | - | $2.37 B(+6.4%) | $8.58 B(+1.6%) |
| June 2020 | - | $2.23 B(-13.3%) | $8.45 B(+0.4%) |
| Mar 2020 | - | $2.57 B(+82.1%) | $8.41 B(+2.9%) |
| Dec 2019 | $8.16 B(-0.2%) | $1.41 B(-37.0%) | $8.17 B(-2.7%) |
| Sept 2019 | - | $2.24 B(+2.1%) | $8.40 B(+3.4%) |
| June 2019 | - | $2.19 B(-5.9%) | $8.13 B(-0.6%) |
| Mar 2019 | - | $2.33 B(+42.2%) | $8.18 B(-0.5%) |
| Dec 2018 | $8.18 B(+3.4%) | $1.64 B(-16.6%) | $8.22 B(+1.3%) |
| Sept 2018 | - | $1.96 B(-12.5%) | $8.11 B(-0.6%) |
| June 2018 | - | $2.25 B(-5.4%) | $8.16 B(+0.9%) |
| Mar 2018 | - | $2.37 B(+54.8%) | $8.09 B(+3.9%) |
| Dec 2017 | $7.91 B(+4.2%) | $1.53 B(-24.0%) | $7.79 B(-2.0%) |
| Sept 2017 | - | $2.01 B(-7.1%) | $7.94 B(+0.5%) |
| June 2017 | - | $2.17 B(+4.7%) | $7.90 B(+2.1%) |
| Mar 2017 | - | $2.07 B(+22.7%) | $7.74 B(+2.0%) |
| Dec 2016 | $7.59 B(+9.7%) | $1.69 B(-14.4%) | $7.58 B(+11.5%) |
| Sept 2016 | - | $1.97 B(-1.7%) | $6.80 B(+1.4%) |
| June 2016 | - | $2.01 B(+4.7%) | $6.71 B(+0.9%) |
| Mar 2016 | - | $1.92 B(+111.4%) | $6.65 B(-4.7%) |
| Dec 2015 | $6.92 B(+3.3%) | $906.12 M(-51.8%) | $6.97 B(-6.8%) |
| Sept 2015 | - | $1.88 B(-3.3%) | $7.48 B(+1.2%) |
| June 2015 | - | $1.94 B(-13.3%) | $7.39 B(+2.0%) |
| Mar 2015 | - | $2.24 B(+58.7%) | $7.25 B(+8.0%) |
| Dec 2014 | $6.70 B(+6.3%) | $1.41 B(-21.2%) | $6.71 B(+1.1%) |
| Sept 2014 | - | $1.79 B(-0.5%) | $6.64 B(+4.7%) |
| June 2014 | - | $1.80 B(+5.7%) | $6.34 B(+3.8%) |
| Mar 2014 | - | $1.70 B(+26.8%) | $6.11 B(+5.3%) |
| Dec 2013 | $6.30 B(+19.4%) | $1.34 B(-10.2%) | $5.80 B(+5.9%) |
| Sept 2013 | - | $1.49 B(-4.7%) | $5.47 B(+3.3%) |
| June 2013 | - | $1.57 B(+12.4%) | $5.30 B(+4.3%) |
| Mar 2013 | - | $1.39 B(+36.8%) | $5.08 B(+5.4%) |
| Dec 2012 | $5.28 B(+13.3%) | $1.02 B(-22.8%) | $4.82 B(+0.9%) |
| Sept 2012 | - | $1.32 B(-2.0%) | $4.78 B(+5.0%) |
| June 2012 | - | $1.35 B(+18.7%) | $4.55 B(+6.5%) |
| Mar 2012 | - | $1.13 B(+16.0%) | $4.27 B(+3.0%) |
| Dec 2011 | $4.66 B(+23.1%) | $977.58 M(-10.6%) | $4.15 B(+3.3%) |
| Sept 2011 | - | $1.09 B(+2.4%) | $4.02 B(+2.5%) |
| June 2011 | - | $1.07 B(+5.8%) | $3.92 B(+2.1%) |
| Mar 2011 | - | $1.01 B(+19.4%) | $3.84 B(+1.7%) |
| Dec 2010 | $3.78 B(+13.6%) | $845.28 M(-15.1%) | $3.77 B(+1.2%) |
| Sept 2010 | - | $995.03 M(+0.8%) | $3.73 B(+3.8%) |
| June 2010 | - | $987.10 M(+4.2%) | $3.59 B(+3.2%) |
| Mar 2010 | - | $947.01 M(+18.5%) | $3.48 B(+4.6%) |
| Dec 2009 | $3.33 B(+13.8%) | $799.48 M(-7.0%) | $3.33 B(+13.2%) |
| Sept 2009 | - | $859.22 M(-1.7%) | $2.94 B(+5.0%) |
| June 2009 | - | $874.32 M(+10.3%) | $2.80 B(+11.0%) |
| Mar 2009 | - | $792.80 M(+92.6%) | $2.52 B(+6.0%) |
| Dec 2008 | $2.93 B(+33.0%) | $411.63 M(-42.7%) | $2.38 B(+8.6%) |
| Sept 2008 | - | $718.81 M(+20.5%) | $2.19 B(+11.4%) |
| June 2008 | - | $596.69 M(-8.3%) | $1.97 B(+4.7%) |
| Mar 2008 | - | $650.48 M(+190.8%) | $1.88 B(+14.8%) |
| Dec 2007 | $2.20 B(+16.1%) | $223.68 M(-54.8%) | $1.64 B(-7.9%) |
| Sept 2007 | - | $494.88 M(-2.7%) | $1.78 B(+4.0%) |
| June 2007 | - | $508.61 M(+24.6%) | $1.71 B(+3.9%) |
| Mar 2007 | - | $408.19 M(+12.2%) | $1.64 B(+1.8%) |
| Dec 2006 | $1.90 B(+13.5%) | $363.90 M(-14.8%) | $1.61 B(+3.8%) |
| Sept 2006 | - | $426.95 M(-3.8%) | $1.56 B(+3.3%) |
| June 2006 | - | $443.88 M(+17.1%) | $1.51 B(+3.3%) |
| Mar 2006 | - | $379.07 M(+24.2%) | $1.46 B(+8.4%) |
| Dec 2005 | $1.67 B(+11.8%) | $305.28 M(-19.1%) | $1.35 B(-2.2%) |
| Sept 2005 | - | $377.50 M(-4.8%) | $1.38 B(+7.1%) |
| June 2005 | - | $396.48 M(+48.8%) | $1.29 B(+7.6%) |
| Mar 2005 | - | $266.44 M(-20.6%) | $1.19 B(+1.1%) |
| Dec 2004 | $1.49 B | $335.65 M(+17.2%) | $1.18 B(-258.8%) |
| Sept 2004 | - | $286.45 M(-6.4%) | -$743.79 M(+327.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2004 | - | $305.95 M(+20.8%) | -$174.15 M(-148.5%) |
| Mar 2004 | - | $253.37 M(-115.9%) | $358.96 M(-57.5%) |
| Dec 2003 | $1.22 B(+31.4%) | -$1.59 B(-285.7%) | $844.54 M(+12.6%) |
| Sept 2003 | - | $856.09 M(+2.0%) | $750.05 M(+0.3%) |
| June 2003 | - | $839.06 M(+13.5%) | $747.75 M(+33.1%) |
| Mar 2003 | - | $738.95 M(-143.9%) | $561.66 M(+5.4%) |
| Dec 2002 | $929.48 M(+15.9%) | -$1.68 B(-297.2%) | $532.93 M(-35.0%) |
| Sept 2002 | - | $853.80 M(+30.8%) | $820.23 M(+7.5%) |
| June 2002 | - | $652.97 M(-8.1%) | $763.23 M(-2.5%) |
| Mar 2002 | - | $710.22 M(-150.8%) | $782.93 M(+6.6%) |
| Dec 2001 | $802.21 M(+22.6%) | -$1.40 B(-275.3%) | $734.28 M(+64.1%) |
| Sept 2001 | - | $796.80 M(+18.5%) | $447.56 M(-70.4%) |
| June 2001 | - | $672.68 M(+1.7%) | $1.51 B(-8.4%) |
| Mar 2001 | - | $661.56 M(-139.3%) | $1.65 B(-4.4%) |
| Dec 2000 | $654.19 M(+18.0%) | -$1.68 B(-190.4%) | $1.73 B(+3.2%) |
| Sept 2000 | - | $1.86 B(+129.8%) | $1.67 B(+164.8%) |
| June 2000 | - | $810.58 M(+9.9%) | $631.91 M(+18.0%) |
| Mar 2000 | - | $737.25 M(-142.4%) | $535.67 M(+7.6%) |
| Dec 1999 | $554.52 M(+53.3%) | -$1.74 B(-311.5%) | $497.68 M(+24.2%) |
| Sept 1999 | - | $821.66 M(+15.0%) | $400.56 M(+21.5%) |
| June 1999 | - | $714.35 M(+2.2%) | $329.62 M(+16.3%) |
| Mar 1999 | - | $699.25 M(-138.1%) | $283.42 M(+49.8%) |
| Dec 1998 | $361.73 M(-31.4%) | -$1.83 B(-344.4%) | $189.17 M(-64.5%) |
| Sept 1998 | - | $750.72 M(+12.4%) | $533.53 M(+30.1%) |
| June 1998 | - | $668.15 M(+10.4%) | $410.22 M(+9.7%) |
| Mar 1998 | - | $605.00 M(-140.6%) | $373.83 M(+8.7%) |
| Dec 1997 | $527.21 M(+0.3%) | -$1.49 B(-337.5%) | $343.90 M(-1.1%) |
| Sept 1997 | - | $627.41 M(-0.7%) | $347.59 M(-2.2%) |
| June 1997 | - | $631.76 M(+9.9%) | $355.50 M(+10.7%) |
| Mar 1997 | - | $575.07 M(-138.7%) | $321.20 M(-8.5%) |
| Dec 1996 | $525.67 M(-2.3%) | -$1.49 B(-334.0%) | $351.00 M(+13.0%) |
| Sept 1996 | - | $635.32 M(+6.3%) | $310.67 M(+22.2%) |
| June 1996 | - | $597.46 M(-1.2%) | $254.25 M(-17.8%) |
| Mar 1996 | - | $604.87 M(-139.6%) | $309.26 M(+10.6%) |
| Dec 1995 | $537.93 M(+17.9%) | -$1.53 B(-363.8%) | $279.55 M(-39.6%) |
| Sept 1995 | - | $578.90 M(-11.3%) | $462.93 M(+7.2%) |
| June 1995 | - | $652.47 M(+13.4%) | $431.98 M(+41.5%) |
| Mar 1995 | - | $575.16 M(-142.8%) | $305.32 M(+57.9%) |
| Dec 1994 | $456.28 M(+7.7%) | -$1.34 B(-345.2%) | $193.31 M(-61.2%) |
| Sept 1994 | - | $547.95 M(+4.2%) | $498.12 M(+20.1%) |
| June 1994 | - | $525.81 M(+13.5%) | $414.84 M(+11.2%) |
| Mar 1994 | - | $463.15 M(-144.6%) | $373.05 M(+13.9%) |
| Dec 1993 | $423.64 M(+37.8%) | -$1.04 B(-323.6%) | $327.44 M(+42.2%) |
| Sept 1993 | - | $464.66 M(-4.0%) | $230.21 M(+4.7%) |
| June 1993 | - | $484.02 M(+15.9%) | $219.90 M(+17.9%) |
| Mar 1993 | - | $417.53 M(-136.8%) | $186.47 M(-3.2%) |
| Dec 1992 | $307.54 M(-1.7%) | -$1.14 B(-350.0%) | $192.69 M(-58.0%) |
| Sept 1992 | - | $454.35 M(+0.8%) | $458.91 M(+27.5%) |
| June 1992 | - | $450.60 M(+6.3%) | $359.94 M(+45.3%) |
| Mar 1992 | - | $423.75 M(-148.7%) | $247.65 M(+17.7%) |
| Dec 1991 | $312.86 M(+22.8%) | -$869.78 M(-344.7%) | $210.43 M(-4.3%) |
| Sept 1991 | - | $355.38 M(+5.1%) | $219.95 M(+10.7%) |
| June 1991 | - | $338.30 M(-12.5%) | $198.62 M(+11.5%) |
| Mar 1991 | - | $386.54 M(-144.9%) | $178.09 M(+99.9%) |
| Dec 1990 | $254.78 M(+22.2%) | -$860.27 M(-357.5%) | $89.08 M(-72.2%) |
| Sept 1990 | - | $334.06 M(+5.1%) | $320.60 M(+45.5%) |
| June 1990 | - | $317.76 M(+6.8%) | $220.29 M(+61.6%) |
| Mar 1990 | - | $297.53 M(-147.3%) | $136.35 M(+19.6%) |
| Dec 1989 | $208.49 M(+11.1%) | -$628.74 M(-369.0%) | $113.96 M(-61.5%) |
| Sept 1989 | - | $233.75 M(-0.0%) | $295.66 M(+19.7%) |
| June 1989 | - | $233.82 M(-15.0%) | $247.03 M(+9.3%) |
| Mar 1989 | - | $275.14 M(-161.5%) | $226.03 M(+66.2%) |
| Dec 1988 | $187.59 M(+40.3%) | -$447.04 M(-341.5%) | $136.02 M(+8.2%) |
| Sept 1988 | - | $185.12 M(-13.0%) | $125.67 M(+3.7%) |
| June 1988 | - | $212.81 M(+15.0%) | $121.19 M(+51.2%) |
| Mar 1988 | - | $185.13 M(-140.5%) | $80.13 M(+12.1%) |
| Dec 1987 | $133.75 M(+20.8%) | -$457.39 M(-353.2%) | $71.49 M(-64.6%) |
| Sept 1987 | - | $180.64 M(+5.2%) | $202.13 M(+34.0%) |
| June 1987 | - | $171.75 M(-2.7%) | $150.89 M(+33.6%) |
| Mar 1987 | - | $176.49 M(-154.0%) | $112.91 M(+105.3%) |
| Dec 1986 | $110.76 M(+24.8%) | -$326.75 M(-352.5%) | $55.00 M(-56.7%) |
| Sept 1986 | - | $129.40 M(-3.3%) | $126.97 M(+35.8%) |
| June 1986 | - | $133.77 M(+12.8%) | $93.51 M(+70.1%) |
| Mar 1986 | - | $118.58 M(-146.5%) | $54.98 M(+90.2%) |
| Dec 1985 | $88.77 M(+24.5%) | -$254.79 M(-365.6%) | $28.90 M(-65.6%) |
| Sept 1985 | - | $95.94 M(+0.7%) | $83.91 M(+5.5%) |
| June 1985 | - | $95.24 M(+3.0%) | $79.51 M(+5.4%) |
| Mar 1985 | - | $92.51 M(-146.3%) | $75.44 M(+0.5%) |
| Dec 1984 | $71.32 M | -$199.77 M(-318.2%) | $75.07 M(-72.7%) |
| Sept 1984 | - | $91.54 M(+0.4%) | $274.84 M(+49.9%) |
| June 1984 | - | $91.16 M(-1.1%) | $183.30 M(+98.9%) |
| Mar 1984 | - | $92.14 M | $92.14 M |
FAQ
- What is Novo Nordisk A/S annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Novo Nordisk A/S?
- What is Novo Nordisk A/S annual EBITDA year-on-year change?
- What is Novo Nordisk A/S quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Novo Nordisk A/S?
- What is Novo Nordisk A/S quarterly EBITDA year-on-year change?
- What is Novo Nordisk A/S TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Novo Nordisk A/S?
- What is Novo Nordisk A/S TTM EBITDA year-on-year change?
What is Novo Nordisk A/S annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of NVO is $16.64 B
What is the all time high annual EBITDA for Novo Nordisk A/S?
Novo Nordisk A/S all-time high annual earnings before interest, taxes, depreciation & amortization is $16.64 B
What is Novo Nordisk A/S annual EBITDA year-on-year change?
Over the past year, NVO annual earnings before interest, taxes, depreciation & amortization has changed by +$5.76 B (+52.86%)
What is Novo Nordisk A/S quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of NVO is $5.51 B
What is the all time high quarterly EBITDA for Novo Nordisk A/S?
Novo Nordisk A/S all-time high quarterly earnings before interest, taxes, depreciation & amortization is $5.51 B
What is Novo Nordisk A/S quarterly EBITDA year-on-year change?
Over the past year, NVO quarterly earnings before interest, taxes, depreciation & amortization has changed by +$721.58 M (+15.08%)
What is Novo Nordisk A/S TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of NVO is $20.15 B
What is the all time high TTM EBITDA for Novo Nordisk A/S?
Novo Nordisk A/S all-time high TTM earnings before interest, taxes, depreciation & amortization is $20.15 B
What is Novo Nordisk A/S TTM EBITDA year-on-year change?
Over the past year, NVO TTM earnings before interest, taxes, depreciation & amortization has changed by +$6.07 B (+43.11%)